Rheumatology Rounds With Dr. Maheswaranathan
Dr. Mithu Maheswaranathan is a rheumatologist at Duke University School of Medicine with an interest in digital medical education and health literacy. Review his expert insights on rheumatoid arthritis, lupus, gout, osteoporosis, spondyloarthritis, and more.
Researchers sought to better address the gap in knowledge on acetaminophen safety in patients with osteoarthritis.
Dr. Mithu Maheswaranathan discusses the link between vitamin D levels and pregnancy outcomes in women with lupus.
A study sought to understand the use of herbal supplement treatment in adult patients with autoimmune skin diseases.
The role of dietary and lifestyle interventions in the management of rheumatic disease is poorly understood.
Dr. Mithu Maheswaranathan on a study that shows metformin is a promising complementary therapy for SLE.
A study assessed glucocorticoid regimens on renal response, infections, and mortality in patients with lupus nephritis.
There is increasing interest in the use of musculoskeletal ultrasound in pediatric rheumatology.
A study analyzed the use of after-visit instructions at rheumatology clinics.
It is critical for physicians to be confident and comfortable in diagnosing and managing knee osteoarthritis.
Mithu Maheswaranathan, MD, spoke about challenges, treatments, and trends in rheumatology, as well as upcoming advancements.
A study aimed to create a benefit-versus-harm shared decision-making tool for hydroxychloroquine for patients with SLE.
A study provided a unique characterization of a rare: large-vessel involvement from ANCA-associated vasculitis.
A study sought to identify variables distinguishing inflammatory from noninflammatory arthritis in a large cohort.
Ultra-low dose rituximab significantly reduced the rate of infections versus the standard low dosage in rheumatoid arthritis.
Researchers examined changes in objective measures of cardiorespiratory function and patient-reported outcomes in lupus.
A study sought to characterize racial differences in lupus clinical manifestations.
VEXAS (vacuoles, E1-ubiquitin-activating enzyme, X-linked, autoinflammatory, somatic) syndrome is a newly discovered ...
Two recent studies presented at the American College of Rheumatology (ACR) Convergence 2022 conference evaluated ANA ...
It has been well demonstrated that patients with systemic autoimmune rheumatic diseases (SARDs) are at higher risk of ...
While efficacy of oral antiviral therapies for SARS-CoV-2 infection have been demonstrated in clinical trials in the ...
“Long COVID” refers to ongoing symptoms or new symptoms that patients experience after acute infection with the ...
The Longitudinal Knowledge Assessment (LKA) was recently launched by the American Board of Internal Medicine for ...
Results of the ORAL Surveillance study were recently published in the NEJM in late January 2022. ORAL Surveillance was ...
A new tool has now entered the armamentarium of medical treatments in the fight against COVID-19: AZD7442, also known as ...
During the ACR Convergence 2021 National Meeting, Dr. Leonard Calabrese and Dr. Cassandra Calabrese, two rheumatologists ...
Two recent studies published in 2021 have evaluated the disparities in rheumatology educational materials, particularly ...
Dr. Mara Becker spoke on the management of adults with JIA including uveitis and macrophage activation syndrome.
The debate discussed benefits and drawbacks of these two agents. See why Dr. Michelle Petri argues in favor of belimumab.
Advertisement
DocWire News delivers the latest medical industry news, giving health care professionals the curated content most relevant to their fields and practices.
Get the latest updates from DocWire News experts, including Dr. Mithu Maheswaranathan.
Advertisement
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.